# ChronoScale Holdings Corp: overview CHRN · Nasdaq · CIK 1549084 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31 Pages: [Overview](/companies/chrn.md) · [Financials](/companies/chrn/financials.md) · [Filings](/companies/chrn/filings.md) · [Insiders](/companies/chrn/insiders.md) Latest reported revenue: [$41.5m](/filings/0001628280-26-065876.md) for Q1 FY2027, three months to 2026-08-31, from the 10-Q filed Oct 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-065876). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-31) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [5.1 d](/filings/0001437749-26-005086.md) | [3.4](/filings/0001437749-26-013682.md) | [2.1](/filings/0001437749-25-023648.md) | [16.7](/filings/0001628280-26-065876.md) | [4.2](/filings/0001437749-25-031960.md) | [3.1 d](/filings/0001437749-26-005086.md) | [2.1](/filings/0001437749-26-013682.md) | [41.5](/filings/0001628280-26-065876.md) | | Gross margin | % | [53.3% d](/filings/0001437749-26-005086.md) | [53.5%](/filings/0001437749-26-013682.md) | [39.8%](/filings/0001437749-25-023648.md) | not reported | [60.3%](/filings/0001437749-25-031960.md) | [53.2% d](/filings/0001437749-26-005086.md) | [50.2%](/filings/0001437749-26-013682.md) | not reported | | Operating margin | % | [(43.8%) d](/filings/0001437749-26-005086.md) | [(101.9%)](/filings/0001437749-26-013682.md) | [(193.2%)](/filings/0001437749-25-023648.md) | [(48.1%)](/filings/0001628280-26-065876.md) | [(33.2%)](/filings/0001437749-25-031960.md) | [(143.6%) d](/filings/0001437749-26-005086.md) | [(262.4%)](/filings/0001437749-26-013682.md) | [(60.0%)](/filings/0001628280-26-065876.md) | | Net margin | % | [(67.1%) d](/filings/0001437749-26-005086.md) | [(85.7%)](/filings/0001437749-26-013682.md) | [(131.7%)](/filings/0001437749-25-031960.md) | [(67.3%)](/filings/0001628280-26-065876.md) | [(33.6%)](/filings/0001437749-25-031960.md) | [(148.9%) d](/filings/0001437749-26-005086.md) | [(321.6%)](/filings/0001437749-26-013682.md) | [(102.4%)](/filings/0001628280-26-065876.md) | | Diluted EPS | $ per share | not reported | [(1.84)](/filings/0001437749-26-013682.md) | [(1.24)](/filings/0001437749-25-023648.md) | [(0.08)](/filings/0001628280-26-065876.md) | [(0.54)](/filings/0001437749-25-031960.md) | not reported | [(2.04)](/filings/0001437749-26-013682.md) | [(0.29)](/filings/0001628280-26-065876.md) | | Free cash flow | $m | [(1.5) d](/filings/0001437749-26-005086.md) | [(2.0)](/filings/0001437749-26-013682.md) | [(3.5) d](/filings/0001437749-25-023648.md) | [(0.9)](/filings/0001628280-26-065876.md) | [(2.1) d](/filings/0001437749-25-031960.md) | [(4.5) d](/filings/0001437749-26-005086.md) | [(2.1)](/filings/0001437749-26-013682.md) | [11.6](/filings/0001628280-26-065876.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY (2025-05-31) | FY2025 (2025-12-31) | FY2026 (2026-05-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [18.3](/filings/0001437749-25-005913.md) | [17.9](/filings/0001437749-26-005086.md) | [84.4](/filings/0001628280-26-058018.md) | [12.8](/filings/0001437749-26-005086.md) | [71.6](/filings/0001628280-26-058018.md) | | Gross margin | % | [49.7%](/filings/0001437749-25-005913.md) | [53.1%](/filings/0001437749-26-005086.md) | not reported | [53.5%](/filings/0001437749-26-005086.md) | not reported | | Operating margin | % | [(82.7%)](/filings/0001437749-25-005913.md) | [(58.4%)](/filings/0001437749-26-005086.md) | [(65.6%)](/filings/0001628280-26-058018.md) | [(104.1%)](/filings/0001437749-26-005086.md) | [(52.4%)](/filings/0001628280-26-058018.md) | | Net margin | % | [(83.1%)](/filings/0001437749-25-005913.md) | [(63.2%)](/filings/0001437749-26-005086.md) | [(86.2%)](/filings/0001628280-26-058018.md) | [(91.4%)](/filings/0001437749-26-005086.md) | [(70.3%)](/filings/0001628280-26-058018.md) | | Diluted EPS | $ per share | [(1.10)](/filings/0001437749-24-006423.md) | [(8.43)](/filings/0001437749-26-005086.md) | [(0.53)](/filings/0001628280-26-058018.md) | [(4.91)](/filings/0001437749-26-005086.md) | [(0.36)](/filings/0001628280-26-058018.md) | | Free cash flow | $m | [(12.2)](/filings/0001437749-25-005913.md) | [(9.9)](/filings/0001437749-26-005086.md) | [(8.6)](/filings/0001628280-26-058018.md) | [(12.0)](/filings/0001437749-26-005086.md) | [12.2](/filings/0001628280-26-058018.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/chrn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Vident Advisory, LLC](/funds/1744347.md) | 2026-06-30 | $7.4m | 333,705 | | New +333,705 | | [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $2.6m | 118,011 | | New +118,011 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $1.6m | 72,275 | | New +72,275 | | [Vontobel Holding Ltd.](/funds/1588340.md) | 2026-06-30 | $1.4m | 61,652 | | New +61,652 | | [Point72 Asset Management, L.P.](/funds/1603466.md) | 2026-06-30 | $1.3m | 59,793 | | New +59,793 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.3m | 57,119 | | New +57,119 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $873.8k | 39,325 | | New +39,325 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $840.6k | 37,831 | | New +37,831 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $835.1k | 37,583 | | New +37,583 | | [Brevan Howard Capital Management LP](/funds/1512857.md) | 2026-06-30 | $704.9k | 31,725 | | New +31,725 | ## Recent filings [All 725 filings](/companies/chrn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 21:08 ET | [8-K](/filings/0001493152-26-047278.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-047278 | | 2026-10-14 | 20:14 ET | [10-Q](/filings/0001628280-26-065876.md) | Quarterly report, period 2026-08-31 | 0001628280-26-065876 | | 2026-10-06 | 21:20 ET | [8-K](/filings/0001493152-26-046010.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-046010 | | 2026-10-02 | 21:27 ET | [8-K](/filings/0001493152-26-045612.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045612 | | 2026-09-25 | 21:15 ET | [DEF 14A](/filings/0001493152-26-044383.md) | Proxy statement, period 2026-09-25 | 0001493152-26-044383 | | 2026-09-16 | 21:05 ET | [8-K](/filings/0001493152-26-042947.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-042947 | | 2026-08-27 | 20:15 ET | [8-K](/filings/0001493152-26-040398.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040398 | | 2026-08-19 | 21:16 ET | [10-K](/filings/0001628280-26-058018.md) | Annual report, period 2026-05-31 | 0001628280-26-058018 | | 2026-08-18 | 20:05 ET | [8-K](/filings/0001493152-26-039008.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-039008 | | 2026-06-30 | 21:14 ET | [8-K/A](/filings/0001493152-26-031317.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-031317 | ## Latest annual report [Form 10-K for the fiscal year ended May 31, 2026](/filings/0001628280-26-058018.md), filed Aug 19, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1549084 - Tickers: CHRN - Exchange: Nasdaq - SIC code: 3569 General Industrial Machinery & Equipment, NEC - State of incorporation: not reported - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.